These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10960037)

  • 41. Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors.
    Deli T; Csernoch L
    Pathol Oncol Res; 2008 Sep; 14(3):219-31. PubMed ID: 18575829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Release of ATP and UTP from astrocytoma cells.
    Harden TK; Lazarowski ER
    Prog Brain Res; 1999; 120():135-43. PubMed ID: 10550993
    [No Abstract]   [Full Text] [Related]  

  • 43. 2-ClATP exerts anti-tumoural actions not mediated by P2 receptors in neuronal and glial cell lines.
    D'Ambrosi N; Costanzi S; Angelini DF; Volpini R; Sancesario G; Cristalli G; Volonté C
    Biochem Pharmacol; 2004 Feb; 67(4):621-30. PubMed ID: 14757162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.
    Eliahu S; Barr HM; Camden J; Weisman GA; Fischer B
    J Med Chem; 2010 Mar; 53(6):2472-81. PubMed ID: 20175517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adenosine and P2 receptors in PC12 cells. Genotypic, phenotypic and individual differences.
    Arslan G; Fredholm BB
    Prog Brain Res; 1999; 120():301-10. PubMed ID: 10551006
    [No Abstract]   [Full Text] [Related]  

  • 46. Uridine nucleotide receptors and their ligands: structural, physiological, and pathophysiological aspects, with special emphasis on the nervous system.
    Heilbronn E; Knoblauch BH; Müller CE
    Neurochem Res; 1997 Aug; 22(8):1041-50. PubMed ID: 9239760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A dual role for purinergic agonists: closer to effective treatment for cystic fibrosis?
    Barker P
    Pediatr Res; 2001 Nov; 50(5):552. PubMed ID: 11641445
    [No Abstract]   [Full Text] [Related]  

  • 48. 2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.
    Eliahu S; Martín-Gil A; Perez de Lara MJ; Pintor J; Camden J; Weisman GA; Lecka J; Sévigny J; Fischer B
    J Med Chem; 2010 Apr; 53(8):3305-19. PubMed ID: 20337495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. P2 receptors in the kidney.
    Bailey MA; Hillman KA; Unwin RJ
    J Auton Nerv Syst; 2000 Jul; 81(1-3):264-70. PubMed ID: 10869730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular recognition in P2 receptors: ligand development aided by molecular modeling and mutagenesis.
    Jacobson KA; Hoffmann C; Kim YC; Camaioni E; Nandanan E; Jang SY; Guo DP; Ji XD; von Kügelgen I; Moro S; Ziganshin AU; Rychkov A; King BF; Brown SG; Wildman SS; Burnstock G; Boyer JL; Mohanram A; Harden TK
    Prog Brain Res; 1999; 120():119-32. PubMed ID: 10550992
    [No Abstract]   [Full Text] [Related]  

  • 51. Developments in P2 receptor targeted therapeutics.
    Williams M
    Prog Brain Res; 1999; 120():93-106. PubMed ID: 10550990
    [No Abstract]   [Full Text] [Related]  

  • 52. Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference.
    Costanzi S; Joshi BV; Maddileti S; Mamedova L; Gonzalez-Moa MJ; Marquez VE; Harden TK; Jacobson KA
    J Med Chem; 2005 Dec; 48(26):8108-11. PubMed ID: 16366591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance.
    Kellerman DJ
    Chest; 2002 May; 121(5 Suppl):201S-205S. PubMed ID: 12010852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and stability of phosphate modified ATP analogues.
    Hacker SM; Mex M; Marx A
    J Org Chem; 2012 Nov; 77(22):10450-4. PubMed ID: 23088633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classification of P2 purinoceptors. Not all G protein-coupled P2 purinoceptors can be classed as P2Y.
    Boarder MR; Turner JT; Erb L; Weisman GA
    Trends Pharmacol Sci; 1994 Aug; 15(8):280-1. PubMed ID: 7802838
    [No Abstract]   [Full Text] [Related]  

  • 56. Bridging the gap between proteins and nucleic acids: a metal-independent RNAseA mimic with two protein-like functionalities.
    Perrin DM; Garestier T; Hélène C
    J Am Chem Soc; 2001 Feb; 123(8):1556-63. PubMed ID: 11456753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stacking interactions in fluorescent nucleotide analogs containing 1-aminonaphthalene-5-sulfonate at the phosphoryl terminus.
    Yarbrough LR; Bock JL
    J Biol Chem; 1980 Oct; 255(20):9907-11. PubMed ID: 6253457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regeneration of cofactors for use in biocatalysis.
    Zhao H; van der Donk WA
    Curr Opin Biotechnol; 2003 Dec; 14(6):583-9. PubMed ID: 14662386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A breath of fresh air for patients with lung disease?
    Sansom C
    Mol Med Today; 1999 Jan; 5(1):5. PubMed ID: 10088119
    [No Abstract]   [Full Text] [Related]  

  • 60. Trophic roles of P2 purinoceptors in central nervous system astroglial cells.
    Abbracchio MP; Ceruti S; Bolego C; Puglisi L; Burnstock G; Cattabeni F
    Ciba Found Symp; 1996; 198():142-7; discussion 147-8. PubMed ID: 8879823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.